GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » KDA Group Inc (TSXV:KDA) » Definitions » Research & Development

KDA Group (TSXV:KDA) Research & Development : C$0.00 Mil (TTM As of Jan. 2024)


View and export this data going back to 2009. Start your Free Trial

What is KDA Group Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. KDA Group's Research & Development for the three months ended in Jan. 2024 was C$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jan. 2024 was C$0.00 Mil.

KDA Group Research & Development Historical Data

The historical data trend for KDA Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

KDA Group Research & Development Chart

KDA Group Annual Data
Trend May14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

KDA Group Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

KDA Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

KDA Group  (TSXV:KDA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

KDA Group Research & Development Related Terms

Thank you for viewing the detailed overview of KDA Group's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

KDA Group (TSXV:KDA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » KDA Group Inc (TSXV:KDA) » Definitions » Research & Development
Comparable Companies
TSXV:PHA TSXV:NLH TSXV:NPTH TSXV:JNH TSXV:ELM TSX:NUMI TSX:AIDX HCA SZSE:300015 SAU:4013 HKSE:06618 XTER:FRE BKK:BDMS XKLS:5225 BSP:RDOR3 XTER:FME UHS CHE NSE:APOLLOHOSP AGL
Traded in Other Exchanges
KDAGF:USA
Address
1351 Notre-Dame East, Suite 300, Thetford Mines, QC, CAN, G6G 0G5
Website
http://www.groupekda.ca
KDA Group Inc provides solutions and services to the Canadian pharmaceutical market. The company's operating segments include Pharmacy Services; Pharmaceutical Solutions and Technology. It generates maximum revenue from the Pharmacy Services segment.
Executives
Tenshi Life Sciences Pte. Limited 10% Security Holder

KDA Group (TSXV:KDA) Headlines

No Headlines